As of June 9, 2025, Blueprint Medicines Corp (BPMC) reports a Graham Number of 54.76.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Blueprint Medicines Corp's Graham Number
Over recent years, Blueprint Medicines Corp's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2024-12-31 | 54.76 |
| 2023-12-31 | 49.90 |
This trend highlights how Blueprint Medicines Corp manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Blueprint Medicines Corp's Graham Number to Peers
To better understand Blueprint Medicines Corp's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Blueprint Medicines Corp (BPMC) | 54.76 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| United Therapeutics Corp (UTHR) | 291.81 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Emergent BioSolutions Inc (EBS) | 57.84 |
Compared to its competitors, Blueprint Medicines Corp's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.